![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: RFX2 |
Gene summary for RFX2 |
![]() |
Gene information | Species | Human | Gene symbol | RFX2 | Gene ID | 5990 |
Gene name | regulatory factor X2 | |
Gene Alias | RFX2 | |
Cytomap | 19p13.3 | |
Gene Type | protein-coding | GO ID | GO:0000003 | UniProtAcc | P48378 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
5990 | RFX2 | LZE4T | Human | Esophagus | ESCC | 1.49e-04 | 5.99e-02 | 0.0811 |
5990 | RFX2 | LZE24T | Human | Esophagus | ESCC | 7.32e-08 | 3.63e-01 | 0.0596 |
5990 | RFX2 | P2T-E | Human | Esophagus | ESCC | 5.13e-17 | 1.30e-01 | 0.1177 |
5990 | RFX2 | P4T-E | Human | Esophagus | ESCC | 1.99e-03 | 1.08e-01 | 0.1323 |
5990 | RFX2 | P5T-E | Human | Esophagus | ESCC | 2.08e-21 | 1.64e-01 | 0.1327 |
5990 | RFX2 | P8T-E | Human | Esophagus | ESCC | 4.84e-17 | 2.45e-01 | 0.0889 |
5990 | RFX2 | P9T-E | Human | Esophagus | ESCC | 6.65e-08 | 1.01e-01 | 0.1131 |
5990 | RFX2 | P10T-E | Human | Esophagus | ESCC | 4.98e-12 | 2.52e-01 | 0.116 |
5990 | RFX2 | P11T-E | Human | Esophagus | ESCC | 2.22e-02 | 9.58e-02 | 0.1426 |
5990 | RFX2 | P12T-E | Human | Esophagus | ESCC | 8.90e-14 | 2.11e-01 | 0.1122 |
5990 | RFX2 | P15T-E | Human | Esophagus | ESCC | 7.60e-11 | 2.23e-01 | 0.1149 |
5990 | RFX2 | P16T-E | Human | Esophagus | ESCC | 2.99e-04 | 3.64e-02 | 0.1153 |
5990 | RFX2 | P20T-E | Human | Esophagus | ESCC | 1.16e-06 | 1.68e-01 | 0.1124 |
5990 | RFX2 | P21T-E | Human | Esophagus | ESCC | 1.51e-19 | 3.66e-01 | 0.1617 |
5990 | RFX2 | P22T-E | Human | Esophagus | ESCC | 9.53e-08 | -9.82e-03 | 0.1236 |
5990 | RFX2 | P23T-E | Human | Esophagus | ESCC | 2.37e-11 | 4.33e-01 | 0.108 |
5990 | RFX2 | P24T-E | Human | Esophagus | ESCC | 3.80e-09 | 5.44e-02 | 0.1287 |
5990 | RFX2 | P26T-E | Human | Esophagus | ESCC | 2.52e-16 | 3.35e-01 | 0.1276 |
5990 | RFX2 | P27T-E | Human | Esophagus | ESCC | 2.22e-17 | 1.44e-01 | 0.1055 |
5990 | RFX2 | P28T-E | Human | Esophagus | ESCC | 3.82e-09 | 1.68e-01 | 0.1149 |
Page: 1 2 3 4 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:001605014 | Esophagus | ESCC | vesicle organization | 211/8552 | 300/18723 | 2.85e-18 | 2.87e-16 | 211 |
GO:0060271 | Lung | IAC | cilium assembly | 55/2061 | 337/18723 | 1.84e-03 | 1.88e-02 | 55 |
GO:0044782 | Lung | IAC | cilium organization | 58/2061 | 368/18723 | 3.15e-03 | 2.75e-02 | 58 |
GO:0010927 | Lung | IAC | cellular component assembly involved in morphogenesis | 21/2061 | 107/18723 | 5.98e-03 | 4.33e-02 | 21 |
GO:00109271 | Lung | AIS | cellular component assembly involved in morphogenesis | 20/1849 | 107/18723 | 3.79e-03 | 3.52e-02 | 20 |
GO:00602711 | Lung | MIAC | cilium assembly | 37/967 | 337/18723 | 1.29e-05 | 9.85e-04 | 37 |
GO:00447821 | Lung | MIAC | cilium organization | 38/967 | 368/18723 | 3.93e-05 | 2.08e-03 | 38 |
GO:001605010 | Skin | AK | vesicle organization | 45/1910 | 300/18723 | 5.44e-03 | 3.02e-02 | 45 |
GO:00109273 | Skin | AK | cellular component assembly involved in morphogenesis | 20/1910 | 107/18723 | 5.45e-03 | 3.02e-02 | 20 |
GO:001605015 | Skin | cSCC | vesicle organization | 135/4864 | 300/18723 | 5.98e-13 | 3.44e-11 | 135 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 2 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
RFX2 | SNV | Missense_Mutation | c.1494N>C | p.Gln498His | p.Q498H | P48378 | protein_coding | deleterious(0.04) | benign(0.013) | TCGA-AC-A23H-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
RFX2 | SNV | Missense_Mutation | c.1799N>A | p.Ala600Asp | p.A600D | P48378 | protein_coding | tolerated(0.05) | benign(0) | TCGA-BH-A0BO-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
RFX2 | insertion | Nonsense_Mutation | novel | c.2155_2156insAGCACCATGTGGGAGGGA | p.Ser719delinsTer | p.S719delins* | P48378 | protein_coding | TCGA-A8-A07R-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Ancillary | zoledronic | SD | ||
RFX2 | insertion | In_Frame_Ins | novel | c.718_719insTGAAATTTCCCAAACAATACTTTTCTTTTTTTGTTTTAGAGC | p.Ser240delinsLeuLysPheProLysGlnTyrPheSerPhePheValLeuGluPro | p.S240delinsLKFPKQYFSFFVLEP | P48378 | protein_coding | TCGA-BH-A0AY-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | SD | |||
RFX2 | SNV | Missense_Mutation | novel | c.851N>G | p.Asp284Gly | p.D284G | P48378 | protein_coding | deleterious(0) | possibly_damaging(0.829) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
RFX2 | SNV | Missense_Mutation | c.187C>T | p.Pro63Ser | p.P63S | P48378 | protein_coding | tolerated(0.2) | benign(0.003) | TCGA-JW-A5VJ-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | PD | |
RFX2 | SNV | Missense_Mutation | c.710N>G | p.Asn237Ser | p.N237S | P48378 | protein_coding | deleterious(0.02) | probably_damaging(0.913) | TCGA-A6-5665-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
RFX2 | SNV | Missense_Mutation | rs200963067 | c.506N>A | p.Arg169His | p.R169H | P48378 | protein_coding | deleterious(0) | probably_damaging(0.953) | TCGA-A6-6653-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
RFX2 | SNV | Missense_Mutation | c.1280A>C | p.Lys427Thr | p.K427T | P48378 | protein_coding | deleterious(0.01) | benign(0.08) | TCGA-AA-3977-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
RFX2 | SNV | Missense_Mutation | c.1424N>A | p.Arg475His | p.R475H | P48378 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-AA-A01R-01 | Colorectum | colon adenocarcinoma | Male | <65 | III/IV | Chemotherapy | 5-fluorouracil | PD |
Page: 1 2 3 4 5 6 7 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |